CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Mastering Cold-Storage Management: Strategies to Minimise Pharmaceutical Losses

In an era where medical advancements are revolutionising healthcare, ensuring the potency and efficacy of pharma-ceuticals is essential.

However, amidst the complex logistics of transporting pharmaceuticals, one critical factor often overlooked is temperature control. As temperatures fluctuate, so does the efficacy and safety of medicinal products. One study found that the pharmaceutical industry loses $35 billion each year to inefficient temperature-controlled logistics. The losses associated with pharmaceutical waste are not only financial. These can delay the delivery of essential drugs and result in environmental damage from the disposal of drugs. So, how can effective cold storage management prevent further losses and reduce the harm caused by ineffective medicines?

Impact of Temperature Fluctuations

Many medications, particularly antibiotics and vaccines, are sensitive to temperature fluctuations. Some products may also be impacted by exposure to adverse humidity levels.

When exposed to temperatures outside the recommended range, these medications can become compromised or lose their potency.

Temperature fluctuations not only compromise the efficacy of the medications but also pose significant health risks when people do not get access to vaccines. This was particularly evident during the Covid-19 pandemic. The vaccines that were developed to protect against the Covid-19 virus had strict temperature requirements, raising concerns about whether they could be adequately stored, especially in developing countries.

Other medications such as monoclonal antibodies, often used for the treatment of cancer, are stored4 at temperatures between −20°C to −80°C. When kept in warm temperatures outside the manufacturer’s recommendations, their efficacy dramatically decreases.

There are multiple stages at which these temperature fluctuations can occur – from the transport of raw materials to the shipping of the finished products internationally. Of course, there are also many instances in which temperature fluctuations cannot be controlled, like when someone has to transport a medication from the pharmacy to their home. One report estimates that around half of the vaccines6 distributed around the world go to waste because of poor temperature management. Another report by the United Nations Environment Programme has assessed that at this spoilage rate, a billion vaccines could be wasted. And it highlighted that even if valued at a non-profit cost of around $10 a vaccine, would still represent a massive loss.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026